Prevention of P. Vivax Malaria During Pregnancy in Bolivia
Status:
Withdrawn
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine which, between weekly prophylaxis or malaria attack
treatment, both by chloroquine, is the most appropriate way to protect women and foetus from
P. vivax malaria infection during pregnancy.
Phase:
Phase 4
Details
Lead Sponsor:
Institut de Recherche pour le Developpement
Collaborators:
Instituto Nacional de Laboratorios de Salud (INLASA) Ministry of Health, Bolivia Pan American Health Organization